Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Neurology Diabetes / Metabolic Rheumatology Gastroenterology Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Clinical Trial ● Currently Recruiting NCT07300254

Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: Implications for Transmission

Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: Implications for Transmission — Recruiting • Infectious Disease • NCT07300254.

📅 03 Apr 2026 ⏱ 3 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT07300254
Sponsor
Monash University
Start
2025-12-02
ClinicaliQ Trial Snapshot
  • Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: Implications for Transmission — Recruiting • Infectious Disease • NCT07300254.
  • How syphilis is transmitted between sexual partners is unclear. Asymptomatic detection i.e. detection of syphilis bacteria (Tp) from anatomical sites without lesions, in patients with syphilis infection, suggests that asymptomatic transmission from these sites may play a role. However, no existing studies….
  • Sponsor: Monash University.

Verify eligibility, endpoints and current status on the original source registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

How syphilis is transmitted between sexual partners is unclear. Asymptomatic detection i.e. detection of syphilis bacteria (Tp) from anatomical sites without lesions, in patients with syphilis infection, suggests that asymptomatic transmission from these sites may play a role. However, no existing studies have established whether the syphilis bacteria (Tp) detected was viable. This means it is not known if the bacteria at this anatomical site is alive and therefore able to transmit the infection. Further, studies have focused mostly on men who have sex with men, resulting in a lack…

Eligibility Snapshot
  • : - 1. Any cis-woman, cis-MSW, or nonbinary individuals with a penis who have sex with women only, (who meet all other study criteria) 2. Aged ≥18 years of age, 3. At least one sexual partner in the last 12 months 4. One of either: a. Untreated clinically suspected primary or secondary syphilis. i. Must have rash or lesion(s) clinically suggestive of early infectious syphilis infection. ii. May have positive PCR result, positive Dark-ground Microscopy result, positive syphilis serology or positive point-of-care syphilis test, but these are not necessary at the time of enrolment. b. Untreated early latent (no clinical signs indicative of primary or secondary syphilis) syphilis with positive syphilis serology or positive point-of-care test, and one or more of the following(11): i. A documented syphilis seroconversion within the prior 12 months. ii. A sustained (longer than 2 weeks) fourfold or greater increase in the titre in the prior 12 months in a person previously treated for syphilis. iii. Unequivocal symptoms of primary or secondary syphilis within the prior 12 months. iv. Contact in the prior 12 months with a sex partner who had untreated primary, secondary, or early latent syphilis. v. Documented reactive nontreponemal and treponemal tests,…

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
HIV Testing: Increasing Uptake Among People Who May Have Undiagnosed HIV (NICE PH33)
Infectious Disease · 27 Mar 2026
Offer opt-out HIV testing in emergency departments, sexual health clinics, and antenatal services to maximise identification of undiagnosed HIV cases without requiring…
View guideline →
Clinical Brief
Increase in drug-resistant Shigella cases among gay and bisexual men
Infectious Disease · UKHSA · 26 Mar 2026
New UKHSA data shows that sexually transmitted Shigella cases in England continue to occur at high levels, with over 2,500 diagnoses in…
View brief →
Guideline
Sepsis: Recognition, Diagnosis and Early Management (NICE NG51)
Infectious Disease · 27 Mar 2026
Use qSOFA tool (altered mental state, systolic BP ≤100 mmHg, respiratory rate ≥22) or NEWS2 score to identify suspected sepsis in adults…
View guideline →
Clinical Brief
Why is MenB vaccine not given to teenagers in UK and should they be offered it?
Infectious Disease · BBC Health · 24 Mar 2026
Students and older teens are not routinely vaccinated against the meningitis strain behind the Kent outbreak. This update is most useful for…
View brief →
Clinical Brief
What are the symptoms of meningitis and how is it spread?
Infectious Disease · BBC Health · 24 Mar 2026
Two people have died following an "unpredecented" outbreak of meningitis in Kent. This update is most useful for vaccination advice, risk communication,…
View brief →
Clinical Brief
What is the UK Covid inquiry and how does it work?
Infectious Disease · BBC Health · 19 Mar 2026
The third report from the inquiry into the government's handling of the pandemic says the NHS was close to collapse. This update…
View brief →